Browsing Harvard Medical School by Keyword "adverse drug reactions"
Now showing items 1-1 of 1
-
NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma
(Public Library of Science, 2007)Background: Somatic genetic CDKN2A, TP53, and DNA content abnormalities are common in many human cancers and their precursors, including esophageal adenocarcinoma (EA) and Barrett's esophagus (BE), conditions for which ...